Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort-Reference-Cited by-同舟云学术

Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort

Published:2021-11-02 Issue: Volume: Page:
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Hirano Tsutomu¹^ORCID,Satoh Noriyuki²,Kodera Rieko¹,Hirashima Takeshi¹,Suzuki Natsuko¹,Aoki Ema¹,Oshima Taito¹,Hosoya Mitsuru¹,Fujita Masahiro¹,Hayashi Toshiyuki³,Ito Yasuki²

Affiliation:

1. Diabetes Center Ebina General Hospital Ebina City Japan

2. Vaccine & Diagnostics R&D Department Denka Co., Ltd Gosen Japan

3. Yurakubashi Clinic Tokyo Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13697

Reference44 articles.

1. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

2. Lipid Abnormalities in Patients with Chronic Kidney Disease: Implications for the Pathophysiology of Atherosclerosis

3. Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis

4. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient

5. Change in dyslipidemia with declining glomerular filtration rate and increasing proteinuria in children with CKD;Saland JM;J Am Soc Nephrol,2019

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease;The Egyptian Journal of Internal Medicine;2024-08-13

2. Association of remnant cholesterol with renal function and its progression in patients with type 2 diabetes related chronic kidney disease;Frontiers in Endocrinology;2024-07-04

3. Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease;Renal Failure;2024-07-02

4. PROFILE OF DIABETIC NEPHROPATHY PATIENTS AT WALED GENERAL HOSPITAL, CIREBON DISTRICT, INDONESIA: HIGH PREVALENCE IN PRODUCTIVE AGE GROUP, FEMALE AND HOUSEWIVES;Journal of Law and Sustainable Development;2024-06-06

5. Phloretamide Protects against Diabetic Kidney Damage and Dysfunction in Diabetic Rats by Attenuating Hyperglycemia and Hyperlipidemia, Suppressing NF-κβ, and Upregulating Nrf2;Pharmaceutics;2024-04-07